For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230921:nRSU2825Na&default-theme=true
RNS Number : 2825N Tintra PLC 21 September 2023
FORM 8 (OPD)
Amendment to section 3b
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Tintra plc
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Tintra plc
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? Offeree
(e) Date position held: 19 September 2023
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security:
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil - Nil -
(2) Cash-settled derivatives: Nil - Nil -
(3) Stock-settled derivatives (including options) and agreements to Nil - Nil -
purchase/sell:
Nil - Nil -
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
(a) Beneficial holdings of the Directors of Tintra plc (including their
close relatives) in its ordinary shares of 1p each
Name Number of ordinary shares held % of voting rights
The Tintra Trust(1) 5,053,611 28.50
Time Machine Capital 2 Limited(2) 636,475 3.59
Dr Joe Lyske 108,002 0.60
Roger Matthews 104,407 0.58
Kathy Cox 30,000 0.16
John Cripps 15,000 0.08
Total 5,947,495 33.51
1- A trust, the beneficiary of which is Tintra Holdings Limited, a company
incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which
in turn is controlled by Richard Shearer, a director of Tintra PLC.
2- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant
Control of Time Machine Capital 2 Ltd.
(b) Beneficial holdings of others being identified as being in concert with
the Offeree (including their close relatives) in its ordinary shares of 1p
each
Name Number of ordinary shares held % of voting rights
Andrew Flitcroft(1) 627,237 3.53
The Tintra Foundation(2) 200,000 1.12
Total 827,237 4.65
1- Andrew Flitcroft is the Company Secretary of Tintra PLC.
2- The Tintra Foundation is an independently managed foundation based in
Switzerland which receives support from Tintra PLC as part of its ESG
strategy.
(c) Rights to subscribe for ordinary shares of Tintra plc (including their
close relatives) in its ordinary shares of 1p each
Name Date of grant Exercise price (p) Expiry date Number outstanding
Warrants
Time Machine Capital 2 Limited(1) 24 Nov 2021 52.5 24 Nov 2026 636,475
Conversion Loan Notes
The Tintra Trust(2) 13 Aug 2021 to 8 Nov 2022 10 13 Aug 2024 to 8 Nov 2025 2,441,770
Total 3,078,245
1- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant
Control of Time Machine Capital 2 Ltd.
2- A trust, the beneficiary of which is Tintra Holdings Limited, a company
incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which
in turn is controlled by Richard Shearer, a director of Tintra PLC.
1- A trust, the beneficiary of which is Tintra Holdings Limited, a company
incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which
in turn is controlled by Richard Shearer, a director of Tintra PLC.
2- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant
Control of Time Machine Capital 2 Ltd.
(b) Beneficial holdings of others being identified as being in concert with
the Offeree (including their close relatives) in its ordinary shares of 1p
each
Name Number of ordinary shares held % of voting rights
Andrew Flitcroft(1) 627,237 3.53
The Tintra Foundation(2) 200,000 1.12
Total 827,237 4.65
1- Andrew Flitcroft is the Company Secretary of Tintra PLC.
2- The Tintra Foundation is an independently managed foundation based in
Switzerland which receives support from Tintra PLC as part of its ESG
strategy.
(c) Rights to subscribe for ordinary shares of Tintra plc (including their
close relatives) in its ordinary shares of 1p each
Name Date of grant Exercise price (p) Expiry date Number outstanding
Warrants
Time Machine Capital 2 Limited(1) 24 Nov 2021 52.5 24 Nov 2026 636,475
Conversion Loan Notes
The Tintra Trust(2) 13 Aug 2021 to 8 Nov 2022 10 13 Aug 2024 to 8 Nov 2025 2,441,770
Total 3,078,245
1- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant
Control of Time Machine Capital 2 Ltd.
2- A trust, the beneficiary of which is Tintra Holdings Limited, a company
incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which
in turn is controlled by Richard Shearer, a director of Tintra PLC.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 21 September 2023
Contact name: Andrew Flitcroft, Company Secretary
Telephone number: 020 3795 0421
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEEDFLFLXKLLBBB